SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-116921
Filing Date
2021-09-17
Accepted
2021-09-17 16:16:19
Documents
6
Period of Report
2021-11-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2125970-2_def14a.htm DEF 14A 1099770
2 GRAPHIC lg_phibrocorp-4c.jpg GRAPHIC 43579
3 GRAPHIC sg_thomasdagger-bw.jpg GRAPHIC 11019
4 GRAPHIC tm2125970d2-bc_ceostock4c.jpg GRAPHIC 149757
5 GRAPHIC tm2125970d2-px_signbw.jpg GRAPHIC 626780
6 GRAPHIC tm2125970d2-px_animalbw.jpg GRAPHIC 430517
  Complete submission text file 0001104659-21-116921.txt   2839004
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-36410 | Film No.: 211260613
SIC: 2834 Pharmaceutical Preparations